Hereditary angioedema: first report of the Brazilian registry and challenges

Background  Hereditary Angio‐oedema (HAE) is a serious medical condition caused by a rare autosomal dominant genetic disorder, in which C1 inhibitor (C1‐INH) function is reduced. There is no organized information on the HAE patient population in Brazil.

[1]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[2]  T. Bowen.  Hereditary angioedema: beyond international consensus - circa December 2010 - The Canadian Society of Allergy and Clinical Immunology Dr. David McCourtie Lecture , 2011, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[3]  M. Maurer,et al.  Long‐term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  U. Nzeako.  Diagnosis and management of angioedema with abdominal involvement: a gastroenterology perspective. , 2010, World journal of gastroenterology.

[5]  H. Longhurst.  Management of acute attacks of hereditary angioedema: potential role of icatibant , 2010, Vascular health and risk management.

[6]  William H. Yang,et al.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.

[7]  H. Farkas.  Pediatric hereditary angioedema due to C1-inhibitor deficiency. , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[8]  B. Zuraw.  HAE therapies: past present and future , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[9]  F. Eidelman.  Hereditary angioedema: New therapeutic options for a potentially deadly disorder , 2010, BMC blood disorders.

[10]  T. Craig,et al.  Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  Diego S. Fernández Romero,et al.  Angioedema hereditario: Historia familiar y manifestaciones clínicas en 58 pacientes , 2009 .

[12]  T. Craig,et al.  When is prophylaxis for hereditary angioedema necessary? , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  A. Sheffer,et al.  The spectrum of chronic angioedema. , 2009, Allergy and asthma proceedings.

[14]  A. Goren,et al.  Hereditary angioedema: new hopes for an orphan disease. , 2008, The Israel Medical Association journal : IMAJ.

[15]  A. Davis.  New treatments addressing the pathophysiology of hereditary angioedema , 2008, Clinical and molecular allergy : CMA.

[16]  L. Mallbris,et al.  The establishment and utility of Sweha-Reg: a Swedish population-based registry to understand hereditary angioedema , 2007, BMC dermatology.

[17]  H. Farkas,et al.  C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients. , 2007, Molecular immunology.

[18]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[19]  F. Huang,et al.  Hereditary angioedema: a family study. , 2005, Asian Pacific journal of allergy and immunology.

[20]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[22]  W. Tremaine,et al.  Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.

[23]  K. Bork,et al.  Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.

[24]  J. Dupont,et al.  Hereditary angioedema. Long-term follow-up of 88 patients. Experience of the Argentine Allergy and Immunology Institute. , 2000, Allergologia et Immunopathologia.

[25]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[26]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.